CooperVision to launch MyDay multifocal at Academy 2021

Article

Company announcements include a new multifocal lens launch and MiSight study data spanning 7 years

The 2021 American Academy of Optometry (AAO) annual meeting is set to feature new multifocal contact lens introductions from CooperVision.

The company plans to launch the new multifocal lens options on Thursday, November 4 in Boston. The launch will include MyDay, a daily disposable multifocal lens that expands on the CooperVision’s popular 1 day family. It also plans to share key findings from its MiSight 1 day myopia control clinical trial.

“Since springtime, we have heard customers and colleagues saying how much they’ve been looking forward to Academy—for the education, the science, the products, and of course the people,” said Melissa Kiewe, Vice President of Marketing (North America) for CooperVision. “We can’t wait to share how CooperVision innovation and partnerships with the optometry community are taking on presbyopia like never before, slowing the progression of myopia, and helping practices extend and deepen their patient relationships.”

MyDay multifocal

The new, daily disposable, multifocal, soft contact lens, MyDay, is designed for patients with presbyopia. MyDay lenses are the first to feature a new Binocular Progressive System- a breakthrough approach that simplifies fit and provides optimal visual acuity at all levels, according to the company.

During the US launch, CooperVision will debut its companion marketing campaign at its booth. Attendees who stop by will be able to insert themselves into a program called “Game On, Presbyopia”.

CooperVision will also introduce decentered, multi-focal optics for its Onefit and Onefit MED+ scleral contact lenses. These design upgrades include a user-friendly, online fitting tool that allows practitioners to align the multifocal optics to the visual axis.

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses diagnostic confusion that can be encountered when identifying macular edema in patients.
In a study, a xenon slide illuminator was employed to mimic natural outdoor colors, allowing researchers to test brightness perception using a brightness-matching method, explains Billy R. Hammond.
ODs share what they learned at this year's Academy meeting and what they plan to take home to their practices.
Christi Closson, OD, FAAO, provides insight on what other ODs learned about Johnson & Johnson's contact lens technology.
Dana Shannon, OD, FAAO, details The Contact Lens Instiute's latest report, The Dropout Dilemma.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
© 2024 MJH Life Sciences

All rights reserved.